NewCopy our AI stock portfolios onAutopilotSee the portfolios →
11,2280%
Followers on Facebook.
Loading...

Sign up to access historical data

Sign up

Month over Month

Followers on Facebook.

May 2026 11,220
Apr 2026 11,174
Mar 2026 11,185
Feb 2026 11,145
Jan 2026 11,108

How many followers does Sarepta Therapeutics have on Facebook?

Sarepta Therapeutics has 11,228 followers on Facebook. This is up by 0.2% in the last 30 days.

Analyzing Facebook Followers, how is Sarepta Therapeutics performing compared to its industry peers?

Sarepta Therapeutics underperforms its industry peers when it comes to Facebook Followers, ranking in the 3rd percentile.

How has the number of Facebook followers for Sarepta Therapeutics changed in the last month?

In the last month, Sarepta Therapeutics' Facebook following has increased by 0.2%. This positive growth indicates a strengthening online presence and growing brand interest.

How does the total number of Facebook followers for Sarepta Therapeutics impact its brand strength and business performance?

Having under 100,000 followers shows Sarepta Therapeutics' is gaining a notable presence on Facebook, potentially enhancing brand awareness and fostering stronger business connections.

Why should an investor in Sarepta Therapeutics track and monitor Facebook Followers?

Tracking Facebook followers for Sarepta Therapeutics', particularly when the count is under 100,000, offers insights into the growing brand presence and audience reach. It's indicative of the company's increasing market influence and can signal emerging business opportunities.

Sign up and get more insights on Sarepta Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.